en · de · es · fr · pt
ghk-cu-notes.peptides6579.com › Faq › Chemical Identity Of Ghk-cu — Deep Dive

Chemical Identity Of Ghk-cu — Deep Dive

By Editorial Desk · published 2026-02-17 · last reviewed 2026-04-11 · Faq

If you have been reading about Stability and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2026-04-11. Numbers and descriptions here follow the published literature rather than marketing material.

Chemical Identity Of GHK-Cu

Published work on GHK-Cu concentrates largely on cell culture systems rather than whole organisms. Frequently used endpoints include collagen synthesis, expression of matrix metalloproteinases, and migration of fibroblasts. Some reports describe antioxidant behavior, while others stress delivery of copper into cells. These mechanisms are proposed rather than demonstrated, and the relative weight of each pathway is unclear. Human trials are few and generally small, so laboratory findings should not be read as confirmed clinical results.

GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide backbone consists of glycine, histidine, and lysine joined in that order. Copper is held through the imidazole nitrogen of histidine and the alpha-amino group at the N-terminus, which together produce a square-planar arrangement around the metal center. The solid appears blue to violet, a color that originates from d-d electronic transitions within the copper coordination sphere. The complex is indexed under CAS number 89030-95-5.

The sequence now called GHK was first reported in the early 1970s after isolation from human plasma, where it was noted to influence liver cell behavior in laboratory preparations. Later work described a copper-binding form and its activity in fibroblast and wound-model experiments. Review articles frequently group the substance with other copper peptides. Concentrations in blood appear to fall with age in several small surveys, although the reason for this trend is not settled. Whether such a decline carries functional consequences remains an open question.

Background and Molecular Identity

The molecular weight and charge of GHK-Cu depend on the pH and the number of coordinated ligands. At neutral pH, the peptide typically binds one copper ion, but ternary complexes with other biomolecules can form. Spectroscopic methods such as electron paramagnetic resonance and circular dichroism are used to study the coordination environment. Reports on the exact geometry vary because the complex is dynamic in solution. Researchers often use synthetic GHK-Cu rather than extracted material to control stoichiometry and purity.

GHK-Cu is a coordination complex formed from the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide binds copper through its histidine imidazole nitrogen, the terminal amino group, and the deprotonated amide nitrogen. This arrangement creates a square-planar or distorted geometry around the metal center, depending on pH and the presence of competing ligands. The complex occurs naturally in human plasma, saliva, and urine at low concentrations, and its sequence is conserved across many vertebrate species.

Discovery of GHK is generally attributed to work in the 1970s that isolated a plasma factor influencing liver cell behavior. Subsequent studies identified the copper-binding tripeptide and its ability to chelate copper with high affinity. Early reports linked the complex to wound healing and tissue remodeling in animal models. The free peptide and the copper-bound form have different properties, so the two are distinguished in the literature. Whether endogenous GHK-Cu serves a single primary physiological role remains an open question.

Ghk-cu at a glance

PropertyValueNotes
Chemical classCopper(II) peptide complexPeptide chain coordinated to a single metal ion
CAS number89030-95-5Indexed for the peptide-copper complex
Molecular formulaC14H22CuN6O4Approximate formula for a one-to-one complex
AppearanceBlue to violet solidColor from copper d-d transitions
Solubility classFreely soluble in waterAlso dispersible in some polar solvents

Stability, Handling, and Analytical Verification

Dry material is normally held cold, commonly at -20 °C for long-term storage and 2 to 8 °C for working quantities, protected from light and moisture. Vials should be allowed to reach room temperature before opening so that condensation does not form on the powder. In liquid formulations the complex is generally kept near neutral to slightly acidic pH, because strongly alkaline conditions favour precipitation of copper hydroxide. Antioxidants or chelate-stabilising excipients are often added, though the specific approaches are proprietary and rarely published in detail.

Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry to confirm the expected mass. Copper content is measured separately by inductively coupled plasma optical emission spectrometry or atomic absorption spectroscopy, because the peptide assay alone does not establish the metal-to-peptide ratio. Visible spectroscopy provides a rapid check on complex integrity through the absorption band in the visible region. Agreement between the peptide assay and the copper assay is the practical test of whether a sample is the intended complex rather than a mixture.

Aqueous solutions of GHK-Cu are less stable than the dry powder. The peptide backbone is vulnerable to hydrolysis at extreme pH, and copper can be stripped from the complex by strong chelating agents such as EDTA or citrate. Oxidising agents and high concentrations of ascorbic acid can reduce copper(II) and change the complex, which is one reason formulators often keep such ingredients in separate phases. How quickly these changes occur under real storage conditions depends on pH, buffer, temperature and packaging, and quantitative data on the subject are limited.

Related pages on this site

Background and Chemical Identity

GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide binds copper through its histidine imidazole nitrogen, its terminal amino group, and a deprotonated amide nitrogen, creating a stable chelate ring. The resulting complex carries a distinctive blue to blue-violet color, which arises from copper d-d electronic transitions. In the solid state it is usually handled as a powder, while in solution the complex can dissociate and re-form depending on pH and competing ligands. The name copper tripeptide-1 is widely used in ingredient listings.

The tripeptide was first isolated from a human plasma filtrate in 1973 during studies of tissue repair factors. Later work detected the free peptide and its copper complex in saliva, urine, and wound fluid, suggesting a natural role in tissue remodeling. Plasma concentrations reported in early literature decline with age, a pattern often cited in discussions of skin aging. Whether these endogenous levels are directly functional or largely incidental remains an open question. The peptide sequence is conserved across mammalian species.

Handling, Stability, and Analytical Verification

Routine handling calls for minimizing freeze-thaw cycles and preparing solutions shortly before use. Glass or inert plastic containers reduce adsorption and metal leaching. Working stocks are often kept at 2–8 °C for short periods, while long-term reference material stays at −20 °C or below. Light protection is prudent because prolonged exposure may accelerate oxidation of the peptide. Documentation of lot number, concentration, and preparation date supports reproducibility in laboratory work.

Analytical verification typically combines reversed-phase high-performance liquid chromatography with ultraviolet-visible detection. The copper complex absorbs visible light near 600–630 nm, giving a characteristic blue signal. Mass spectrometry confirms molecular mass and can detect free peptide or mismatched copper stoichiometry. Copper content is often measured independently by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy. Purity, counterion identity, and residual solvents are additional quality-control parameters that methods may address.

Solid GHK-Cu is generally stored as a dry powder under frozen conditions to limit degradation. The peptide bond can hydrolyze, and the copper center can be displaced by strong chelators such as EDTA. Aqueous solutions are less stable than the solid and may lose color or form precipitates over time. Temperature, pH, and oxygen exposure are the main variables that affect shelf life. Neutral to slightly acidic conditions tend to preserve the complex better than strongly alkaline media.

Discovery, Naming, and Basic Chemistry

GHK-Cu is the copper-binding complex formed by the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The free peptide is usually written as GHK, and the complex is written as GHK-Cu or Cu-GHK. The sequence was identified in human plasma and later detected in saliva and urine. Its name comes from the single-letter codes of glycine, histidine and lysine. The complex is widely described as a naturally occurring carrier of copper in blood rather than as a free peptide with its own hormonal role.

Copper binds to the peptide through the histidine imidazole nitrogen and the terminal amino group, forming a stable square-planar complex. Binding constants reported for copper(II) with GHK are high, so the peptide competes effectively for copper in solution. The complex absorbs visible light, which gives solutions a blue to violet colour. Whether the metal-free peptide has a distinct biological function of its own is still an open question; some work treats it mainly as a copper delivery vehicle, while other work reports peptide-specific effects.

The compound was first isolated from human plasma in the 1970s by Loren Pickart, who later described copper-binding activity in liver and other tissues. Early reports focused on its presence in blood and its ability to carry copper between proteins. Commercial and cosmetic use of the term 'copper peptide' has since broadened, and labels rarely distinguish GHK-Cu from other copper-binding fragments. This naming overlap makes literature searching harder, because cosmetic ingredient lists, supplier catalogues and laboratory papers use different vocabularies for the same molecule.

Reference notes

=== 26 March === The SAF retook Khartoum International Airport and the Manshiya Bridge over the Blue Nile in Khartoum. It also retook the Tiba al-Hassanab camp in Jabal Aulia, which is described as the RSF's last stronghold in Khartoum and its main base in central Sudan. Al-Burhan visited the presidential palace in Khartoum and announced the liberation of the city, proclaiming that "Khartoum is free".

=== Workforce === CMS employs over 6,000 people, of whom about 4,000 are located at its headquarters in Woodlawn, Maryland. The remaining employees are located in the Hubert H. Humphrey Building in Washington, D.C., the 10 regional offices listed below, and in various field offices located throughout the United States. The head of CMS is the administrator of the Centers for Medicare & Medicaid Services. The position is appointed by the president and confirmed by the Senate. On May 27, 2021, Chiquita Brooks-LaSure was sworn in as administrator, the first black woman to serve in the role.

== Redox-Neutral Radical Cross-Coupling == In 2025, the Baran laboratory reported a general platform for "redox-neutral radical cross-coupling" employing sulfonyl hydrazides as stable, crystalline radical precursors. These reagents, prepared from a variety of feedstocks (including alcohols, carbonyl compounds, amines, and hydrazines), function as dual-purpose agents: they generate alkyl radicals while donating electrons to activate the nickel catalyst. This eliminates the need for external redox additives, photoredox catalysts, electrochemical setups, or pyrophoric organometallic reagents. The reactions operate under Suzuki-like conditions—an inexpensive nickel catalyst, mild base, and gentle heating—with nitrogen gas as the sole byproduct. The platform enables C–C bond-forming transformations with multiple partner classes, including activated olefins (Giese-type additions), alkyl halides, redox-active esters, (hetero)aryl halides, alkenyl halides, alkynyl halides, and trifluoromethylating reagents. These couplings forge C(sp³)–C(sp³), C(sp³)–C(sp²), and C(sp³)–C(sp) bonds and have been adopted in medicinal chemistry programs for the rapid assembly of complex, sp³-rich scaffolds and fragment libraries. Later in 2025, the same sulfonyl hydrazide platform was extended to achieve stereospecific (stereoretentive) radical cross-couplings. Using readily accessible enantioenriched sulfonyl hydrazides and an achiral nickel catalyst, the method delivers high levels of stereoretention through an inner-sphere mechanism.

== History == Atomoxetine is manufactured, marketed, and sold in the United States as the hydrochloride salt (atomoxetine HCl) under the brand name Strattera by Eli Lilly and Company, the original patent-filing company and current U.S. patent owner. Atomoxetine was initially intended to be developed as an antidepressant, but it was found to be insufficiently efficacious for treating depression. It was, however, found to be effective for ADHD and was approved by the FDA in 2002, for the treatment of ADHD. Its patent expired in May 2017. On 12 August 2010, Lilly lost a lawsuit that challenged its patent on Strattera, increasing the likelihood of an earlier entry of a generic into the US market. On 1 September 2010, Sun Pharmaceuticals announced it would begin manufacturing a generic in the United States. In a 29 July 2011 conference call, however, Sun Pharmaceutical's Chairman stated "Lilly won that litigation on appeal so I think [generic Strattera]'s deferred." In 2017 the FDA approved the generic production of atomoxetine by four pharmaceutical companies.

== January 20, 1982 (Wednesday) == Musician Ozzy Osbourne was treated for rabies after allegedly biting the head off a live bat during a concert at Veterans Auditorium in Des Moines, Iowa. A spokesman for Broadlawn Medical Center reported that the patient registered as John M. Osbourne "was given a rabies shot and rabies vaccine and a tetanus shot as well," and that the medical report gave the history "Patient bit head off bat." Des Moines police lieutenant Derald Leaming said "I told his manager if he bit the head off any animals while he was here, he'd be arrested. We would have arrested him on the spot if we'd seen anything like that," while two other officers said that he had seen Osbourne "put a couple of birds in his mouth but he let them loose", and that although the police didn't see a bat, that they "did see raw liver on the floor." Born: Pete Buttigieg, American politician, U.S. Secretary of Transportation from 2021 to 2025, 2020 candidate for the Democratic Party nomination for U.S. president; in South Bend, Indiana Died: Marc Demeyer, 31, Belgian professional bicyclist known for winning individual stages twice in the Tour de France (1978 and 1979) and twice in the 1977 Giro d'Italia, died of a heart attack.

Sources: en.wikipedia.org

Reference notes

A language model may associate certain professions with specific genders if such patterns are prevalent in the data. Similarly, some image generation systems have been observed to generate images of men as CEOs more often than women. AI software, when using voice recognition software in particular, struggles to recognize and understand speech impediments. For example, people with a stutter struggle to activate voice-activated assistants such as Gemini and Siri due to how the software was trained. Companies that use AI systems to hire for new positions also filter out people with accents and speech due to voice recognition software incorrectly transcribing how candidates speak during the interview process. Because of this, people with disabilities and uncommon accents don't often make it to a human interviewer when these generative AI systems are used. This is due to many AI models being trained and produced in the United States, and therefore, off of American accents.

On 15 April 2023, the country's paramilitary Rapid Support Forces launched attacks against al-Burhan's government, claiming to capture key government sites. Al-Burhan claimed these sites were still under the control of his forces, and that fighting was ongoing. The clashes continued until at least 21 April with occasional ceasefires. Al-Burhan was pinned down at SAF headquarters in Khartoum until August 2023, when a military operation enabled him to evacuate to Port Sudan, where he has been based since then. The Sudanese military allegedly received support from Ukraine. Ukraine has also allegedly sent troops to fight in Omdurman. Their rival, the Rapid Support Forces, had reportedly received support from Libya and the United Arab Emirates as well as Russia's Wagner Group. The foreign involvement in the regional war could have a devastating effect on Sudan. Al-Burhan survived an assassination attempt while attending a military graduation ceremony in Gebeit, in July 2024. Five people were killed in the drone attack. In August 2025, a military official in Sudan confirmed that al-Burhan's envoy, Al-Sadiq Ismail, visited Israel in a push to speed the process of formal normalization between both countries through the Abraham Accords, which has been delayed due to the war. It was reported that Sudan wanted Israeli support following the capture of Khartoum by the SAF in exchange for Sudan's recognition.

Natural platelet-derived antimicrobial peptides have been discovered to play pivotal roles in platelet-dependent immune response beyond synthetic modifications. Platelet microbicidal proteins (PMPs), kinocidins, and cationic host defense peptides (CHDPs) are active against a wide range of pathogens through membrane disruption and immune signaling. By mimicking or enhancing these natural antimicrobial functions, synthetic platelets can potentially serve as a novel therapeutic tool for infection prevention. The implementation of antimicrobial platelets are relevant in the context of currently increasing rates of antibiotic resistance and hospital-acquired infection. Compared to conventional antibiotics, artificial platelets may be able to deliver a localized and specific response to infection, which limits the necessity for systemic antimicrobial therapy and decreases the potential for resistance emergence. As research on this subject continues to grow, antimicrobial platelets may be of consideration in trauma medicine, postoperative recovery, and other clinical practices to optimize immune defense.

== Analytical method for residues in livestock == In cattle and swine tissue, it was found in 2007 that a procedure for the analysis of ractopamine residues in liver or muscle can be performed by high performance liquid chromatography (HPLC) with fluorescence detection. The confirmatory method include reversed-phase HPLC/electrospray ionization triple tandem quadrupole mass spectrometry. The limit of quantification of the drug using this LC/MS instrument was shown to be 1 ng/g (1 ppb). In cattle, a 2018 Chinese study promoted the use of hair as an indelible test of feed containing ractopamine.

Sources: en.wikipedia.org

Notes from published material

A poultice or cataplasm, also called a fomentation, is a soft moist mass, often heated and medicated, that is applied to the skin to reduce inflammation, soothe pain, promote healing, or otherwise treat wounds or ailments. Soft materials like cereals serve as a base for agents intended to affect the body transdermally. The preparation is usually spread on cloth, which is then applied to the area being treated. The cloth is used to keep the preparation in place, or additional bandaging to hold the poultice may be employed. Direct topical application (without cloths) is also used. The term "poultice" may also refer to a porous solid, filled with a solvent, and used to remove stains from porous stone such as marble or granite.

Brown sugars are granulated sugars, either containing residual molasses, or with the grains deliberately coated with molasses to produce a light- or dark-coloured sugar such as muscovado and turbinado. They are used in baked goods, confectionery, and toffees. Their darkness is due to the amount of molasses they contain. They may be classified based on their darkness or country of origin.

17 November – Anton Hull, a drink-driver who filmed himself at the wheel saying he was "smashed" then went on to bill 29-year-old Sarah Baker in a crash in Somerset, is sentenced to six years imprisonment and given a nine-year driving ban. 18 November – Businesses in London have urged the UK government to relax Sunday trading hours because of the cost of living crisis, estimating longer trading hours would generate an extra £300m a year. A study of Bradford's Pakistani community finds that cousin marriage has dropped sharply over the past decade, with 60% of parents born to cousins ten years ago compared to 46% now. Ice hockey team Nottingham Panthers play their first game since the death of Adam Johnson. The Adam Johnson Memorial Game is played against Manchester Storm. 19 November – An earthquake measuring 2.7 magnitude strikes parts of Cornwall at 12.50am. 20 November – Four men are convicted of the August 2022 murder of Ashley Dale in Liverpool following a disagreement involving her boyfriend. 21 November – North Hertfordshire Museum announces it will reclassify the Roman Emperor Elagabalus as a trans woman in its display about the historical figure because classical texts claim the emperor once said "call me not Lord, for I am a Lady". 22 November – James Witham, Joseph Peers, Niall Barry, and Sean Zeisz are each sentenced to life imprisonment with minimum terms of over 40 years for the murder of Ashley Dale. 23 November – A man is shot dead by armed police in Dagenham after telling Met officers he wanted to kill himself and had loaded guns.

Sources: en.wikipedia.org

Frequently asked questions

What is GHK-Cu?

It is the copper complex of the tripeptide glycyl-L-histidyl-lysine. The metal ion is held by the histidine imidazole group and the peptide N-terminus. Most research on it concerns skin and wound models.

Where does the GHK sequence come from?

The tripeptide was first isolated from human plasma and has also been reported in saliva and urine. Plasma levels appear to decline with age in some small studies. Those observations rest on limited sample sizes.

Is GHK-Cu an approved drug?

It is not authorized as a systemic medicine in most countries. Cosmetic preparations list it as an ingredient rather than an active pharmaceutical substance. Legal status therefore differs by jurisdiction.

What is GHK-Cu?

GHK-Cu is a complex of the tripeptide glycyl-L-histidyl-L-lysine with copper(II). The peptide coordinates the metal through its histidine imidazole, terminal amino group, and amide nitrogen. It is studied in biochemistry and dermatological research.

Network